cache/9cf7958f46a76a2ade518855a079b3337822336631185774c69fcd987b7dff9f

COM:ONO-PHARMA

小野薬品工業株式会社

  • Stock

JPY

Last Close

1,747.50

25/11 06:45

Market Cap

1.05T

Beta: -

Volume Today

4.63M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
average inventory
23.82B
-
25.02B
5.03%
24.52B
2.00%
24.28B
0.96%
28.31B
16.59%
32.06B
13.22%
32.86B
2.52%
36.03B
9.63%
40.48B
12.37%
43.32B
6.99%
46.72B
7.86%
average payables
7.54B
-
12.29B
63.01%
22.50B
83.05%
31.08B
38.14%
32.46B
4.45%
35.42B
9.13%
35.64B
0.60%
36.80B
3.27%
44.43B
20.72%
58.24B
31.10%
34.36B
41.00%
average receivables
48.61B
-
42.10B
13.39%
52.00B
23.52%
67.65B
30.09%
75.42B
11.48%
76.93B
2.01%
76.56B
0.48%
80.55B
5.21%
92.03B
14.25%
107.09B
16.37%
125.23B
16.94%
book value per share
844.50
-
887.88
5.14%
889.37
0.17%
979.42
10.13%
1.01K
3.28%
1.08K
7.17%
1.12K
2.95%
1.27K
14.08%
1.32K
3.76%
1.52K
15.00%
1.66K
9.51%
capex per share
-24.26
-
-58.71
142.04%
-26.57
54.75%
-45.43
71.00%
-57.56
26.70%
-57.58
0.03%
-44.54
22.65%
-40.66
8.71%
-24.73
39.17%
-29.69
20.06%
43.39
246.16%
capex to depreciation
-2.52
-
-5.10
102.71%
-2.16
57.75%
-3.08
42.85%
-3.24
5.19%
-2.79
13.94%
-1.58
43.34%
-1.28
18.77%
-0.69
45.99%
-0.83
19.91%
1.15
238.22%
capex to operating cash flow
-0.45
-
-0.99
117.84%
-1.10
11.28%
-0.32
70.51%
-1.90
486.61%
-0.44
76.63%
-0.30
31.73%
-0.27
9.37%
-0.20
27.61%
-0.09
54.26%
0.19
307.23%
capex to revenue
-0.09
-
-0.23
155.35%
-0.09
61.67%
-0.10
11.96%
-0.11
15.85%
-0.10
10.00%
-0.08
25.16%
-0.07
14.52%
-0.03
48.22%
-0.03
4.58%
0.04
227.82%
cash per share
241.69
-
241.11
0.24%
250.68
3.97%
310.75
23.96%
165.47
46.75%
139.01
15.99%
199.25
43.34%
210.31
5.55%
235.61
12.03%
336.45
42.80%
426.23
26.68%
days of inventory on hand
270.09
-
268.07
0.75%
204.21
23.82%
141.12
30.89%
174.65
23.76%
142.91
18.18%
151.91
6.30%
166.99
9.93%
163.22
2.26%
148.62
8.95%
139.62
6.05%
days payables outstanding
120.78
-
142.79
18.22%
274.69
92.38%
172.16
37.33%
189.87
10.29%
160.37
15.53%
158.99
0.86%
167.04
5.07%
193.95
16.11%
221.51
14.21%
174.25
21.33%
days sales outstanding
107.63
-
112.80
4.80%
141.28
25.25%
109.23
22.69%
108.14
0.99%
96.47
10.80%
95.90
0.58%
99.45
3.70%
100.79
1.35%
93.37
7.36%
98.80
5.81%
debt to assets
0.00
-
0.00
42.67%
0.00
35.47%
0.00
0.19%
0.00
25.22%
0.00
187.37%
0.01
269.67%
0.01
2.36%
0.01
1.77%
0.01
12.75%
debt to equity
0.00
-
0.00
41.14%
0.00
39.33%
0.00
3.95%
0.00
26.96%
0.00
190.72%
0.01
276.58%
0.01
4.17%
0.01
5.79%
0.01
7.91%
dividend yield
0.02
-
0.01
34.21%
0.01
43.01%
0.02
118.24%
0.01
16.74%
0.02
41.87%
0.02
6.56%
0.02
14.39%
0.02
16.79%
0.02
21.24%
0.03
42.40%
earnings yield
0.02
-
0.01
58.02%
0.01
9.72%
0.05
361.85%
0.03
35.53%
0.05
55.98%
0.05
3.75%
0.05
9.72%
0.05
1.17%
0.08
57.89%
0.11
29.32%
enterprise value
843.75B
-
1.34T
58.32%
2.42T
80.86%
1.08T
55.46%
1.64T
52.69%
1.06T
35.22%
1.19T
12.02%
1.39T
16.63%
1.46T
5.13%
1.26T
13.62%
1.03T
18.62%
enterprise value over ebitda
24.36
-
54.59
124.13%
60.25
10.38%
13.02
78.38%
22.45
72.41%
14.02
37.56%
12.58
10.25%
11.90
5.42%
11.83
0.63%
7.80
34.04%
5.65
27.60%
ev to operating cash flow
29.69
-
42.30
42.50%
188.13
344.73%
14.45
92.32%
104.47
622.80%
15.94
84.74%
16.08
0.87%
18.80
16.91%
23.64
25.78%
7.91
66.54%
9.29
17.38%
ev to sales
5.89
-
9.84
67.04%
15.07
53.20%
4.40
70.84%
6.27
42.75%
3.69
41.24%
4.08
10.57%
4.50
10.27%
4.05
10.02%
2.82
30.20%
2.04
27.60%
free cash flow per share
29.37
-
0.87
97.04%
-2.34
368.96%
95.04
4,162.27%
-27.22
128.64%
72.30
365.61%
102.61
41.92%
107.55
4.82%
99.81
7.20%
297.18
197.74%
187.14
37.03%
free cash flow yield
0.02
-
0.00
98.05%
-0.00
253.31%
0.04
8,499.53%
-0.01
120.04%
0.03
500.88%
0.04
24.59%
0.04
9.83%
0.03
12.53%
0.11
230.28%
0.08
29.49%
graham net net
260.23
-
231.67
10.98%
239.27
3.28%
262.37
9.65%
154.32
41.18%
102.65
33.48%
137.06
33.53%
164.42
19.96%
272.31
65.62%
282.34
3.69%
449.77
59.30%
graham number
854.14
-
699.36
18.12%
971.11
38.86%
1.52K
56.84%
1.49K
2.44%
1.56K
5.24%
1.72K
10.30%
2.08K
20.63%
2.20K
5.53%
2.81K
27.94%
3.15K
12.06%
income quality
0.96
-
1.73
78.80%
0.39
77.63%
1.00
158.77%
0.25
75.37%
1.03
316.64%
0.93
9.23%
0.73
21.20%
0.59
19.71%
1.11
88.89%
0.86
22.24%
intangibles to total assets
0.05
-
0.06
38.46%
0.07
9.69%
0.07
3.32%
0.09
24.83%
0.10
5.26%
0.10
2.48%
0.09
4.55%
0.09
7.00%
0.08
10.54%
0.06
19.97%
interest coverage
347.67
-
220.81
36.49%
104.84
52.52%
278.02
165.19%
1.69K
506.32%
413.40
75.48%
91.71
77.82%
717.74
682.66%
118.07
83.55%
155.49
31.69%
712.24
358.06%
interest debt per share
1.98
-
1.27
36.21%
2.14
68.99%
2.31
8.03%
1.44
37.57%
4.57
216.78%
18.27
299.63%
18.41
0.79%
19.49
5.86%
20.65
5.93%
0.48
97.69%
inventory turnover
1.35
-
1.36
0.75%
1.79
31.27%
2.59
44.71%
2.09
19.20%
2.55
22.22%
2.40
5.93%
2.19
9.03%
2.24
2.31%
2.46
9.83%
2.61
6.44%
invested capital
0.00
-
0.00
41.14%
0.00
39.33%
0.00
3.95%
0.00
26.96%
0.00
190.72%
0.01
276.58%
0.01
4.17%
0.01
5.79%
0.01
7.91%
472.01B
3,819,492,478,490,301.50%
market cap
947.67B
-
1.44T
51.90%
2.53T
75.45%
1.22T
51.64%
1.71T
39.80%
1.12T
34.29%
1.25T
11.66%
1.44T
15.14%
1.52T
5.52%
1.35T
11.33%
1.18T
12.21%
net current asset value
161.56B
-
148.49B
8.09%
159.38B
7.33%
177.78B
11.55%
129.86B
26.96%
102.30B
21.22%
119.80B
17.11%
141.96B
18.49%
203.74B
43.52%
210.48B
3.31%
298.53B
41.84%
net debt to ebitda
-3.00
-
-4.23
41.15%
-2.73
35.42%
-1.76
35.66%
-0.88
49.85%
-0.76
13.73%
-0.64
15.92%
-0.44
30.48%
-0.49
9.64%
-0.54
10.11%
-0.86
60.89%
net income per share
38.39
-
24.48
36.23%
47.13
92.49%
105.27
123.36%
97.00
7.85%
100.25
3.35%
118.47
18.17%
151.11
27.56%
162.19
7.33%
230.85
42.33%
266.61
15.49%
operating cash flow per share
53.62
-
59.58
11.11%
24.23
59.34%
140.47
479.75%
30.34
78.40%
129.88
328.11%
147.14
13.29%
148.21
0.72%
124.54
15.97%
326.87
162.46%
230.54
29.47%
payables turnover
3.02
-
2.56
15.41%
1.33
48.02%
2.12
59.56%
1.92
9.33%
2.28
18.39%
2.30
0.87%
2.19
4.82%
1.88
13.87%
1.65
12.44%
2.09
27.12%
receivables turnover
3.39
-
3.24
4.58%
2.58
20.16%
3.34
29.35%
3.38
1.00%
3.78
12.10%
3.81
0.59%
3.67
3.56%
3.62
1.33%
3.91
7.95%
3.69
5.49%
research and ddevelopement to revenue
0.31
-
0.30
1.78%
0.27
11.15%
0.23
13.18%
0.26
11.89%
0.24
7.72%
0.23
6.24%
0.20
11.30%
0.21
4.10%
0.21
1.54%
0.22
4.67%
return on tangible assets
0.04
-
0.03
39.80%
0.05
88.11%
0.10
96.00%
0.09
6.83%
0.09
4.17%
0.10
12.98%
0.11
13.35%
0.12
7.08%
0.14
16.10%
0.15
7.82%
revenue per share
270.27
-
256.18
5.21%
302.40
18.04%
461.86
52.73%
505.09
9.36%
561.41
11.15%
580.23
3.35%
619.64
6.79%
727.88
17.47%
915.80
25.82%
1.05K
14.35%
roe
0.05
-
0.03
39.35%
0.05
92.17%
0.11
102.83%
0.10
10.78%
0.09
3.57%
0.11
14.79%
0.12
11.81%
0.12
3.44%
0.15
23.77%
0.16
6.22%
roic
0.04
-
0.02
44.83%
0.05
115.77%
0.10
113.61%
0.09
12.80%
0.09
3.51%
0.10
14.35%
0.11
11.97%
0.12
4.57%
0.15
24.80%
0.16
9.49%
sales general and administrative to revenue
0.27
-
0.31
16.06%
0.27
11.77%
0.25
7.62%
0.26
2.54%
0.24
6.65%
0.23
4.61%
0.22
3.29%
0.21
4.73%
0.20
6.16%
0.20
0.32%
shareholders equity per share
844.50
-
887.88
5.14%
889.37
0.17%
979.42
10.13%
1.01K
3.28%
1.08K
7.17%
1.12K
2.95%
1.27K
14.08%
1.32K
3.76%
1.52K
15.00%
1.65K
8.73%
stock based compensation to revenue
tangible asset value
429.31B
-
441.30B
2.79%
437.93B
0.76%
478.97B
9.37%
473.90B
1.06%
499.68B
5.44%
501.59B
0.38%
570.84B
13.81%
596.94B
4.57%
678.68B
13.69%
741.32B
9.23%
tangible book value per share
809.99
-
832.65
2.80%
826.24
0.77%
903.69
9.37%
914.18
1.16%
971.91
6.31%
995.26
2.40%
1.14K
14.91%
1.20K
5.14%
1.39K
15.59%
1.54K
11.12%
working capital
167.71B
-
162.87B
2.89%
171.38B
5.23%
188.10B
9.76%
141.00B
25.04%
111.47B
20.94%
133.89B
20.12%
153.91B
14.95%
215.34B
39.91%
222.17B
3.17%
309.97B
39.52%

All numbers in JPY (except ratios and percentages)